181
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Effects of octenidine mouth rinse on apoptosis and necrosis of human fibroblasts and epithelial cells – an in vitro study

, , , , , & show all
Pages 182-187 | Received 26 Apr 2016, Accepted 28 May 2017, Published online: 03 Jul 2017

References

  • Alleyn, C.D., et al., 1991. The effect of chlorhexidine treatment of root surfaces on the attachment of human gingival fibroblasts in vitro. Journal of Periodontology, 62 (7), 434–438.
  • Auschill, T.M., et al., 2005. Effect of two antimicrobial agents on early in situ biofilm formation. Journal of Clinical Periodontology, 32 (2), 147–152.
  • Balloni, S., et al., 2016. Cytotoxicity of three commercial mouthrinses on extracellular matrix metabolism and human gingival cell behaviour. Toxicology In Vitro, 34, 88–96.
  • Brunner, E., Domhof, S., and Langer, F., 2002. Nonparametric analysis of longitudinal data in factorial experiments, New York: Wiley.
  • Cabral, C.T., and Fernandes, M.H., 2007. In vitro comparison of chlorhexidine and povidone-iodine on the long-term proliferation and functional activity of human alveolar bone cells. Clinical Oral Investigations, 11 (2), 155–164.
  • Chen, H., et al., 2016. Cytotoxicity of modified nonequilibrium plasma with chlorhexidine digluconate on primary cultured human gingival fibroblasts. Journal of Huazhong University of Science and Technology, 36 (1), 137–141.
  • Cousido, M.C., et al., 2010. In vivo substantivity of 0.12% and 0.2% chlorhexidine mouthrinses on salivary bacteria. Clinical Oral Investigations, 14 (4), 397–402.
  • Cronan, C.A., et al., 2006. Inhibition of Porphyromonas gingivalis proteinases (gingipains) by chlorhexidine: synergistic effect of Zn(II). Oral Microbiology and Immunology, 21 (4), 212–217.
  • Decker, E.M., et al., 2016. Antimicrobial efficiency of mouthrinses versus and in combination with different photodynamic therapies on periodontal pathogens in an experimental study. Journal of Periodontal Research, 52 (2), 162–175.
  • Eick, S., et al., 2011. Efficacy of chlorhexidine digluconate-containing formulations and other mouthrinses against periodontopathogenic microorganisms. Quintessence International (Berlin, Germany: 1985), 42 (8), 687–700.
  • Faria, G., et al., 2009. Chlorhexidine-induced apoptosis or necrosis in L929 fibroblasts: a role for endoplasmic reticulum stress. Toxicology and Applied Pharmacology, 234 (2), 256–265.
  • Feres, M., et al., 2010. The effectiveness of a preprocedural mouthrinse containing cetylpyridinium chloride in reducing bacteria in the dental office. Journal of the American Dental Association (1939), 141 (4), 415–422.
  • Giannelli, M., et al., 2008. Effect of chlorhexidine digluconate on different cell types: a molecular and ultrastructural investigation. Toxicology In Vitro, 22 (2), 308–317.
  • Hagi-Pavli, E., et al., 2014. Characterizing the immunological effects of oral healthcare ingredients using an in vitro reconstructed human epithelial model. Food Chemical Toxicology, 74, 139–148.
  • John, G., Becker, J., and Schwarz, F., 2014. Effects of taurolidine and chlorhexidine on SaOS-2 cells and human gingival fibroblasts grown on implant surfaces. The International Journal of Oral and Maxillofacial Implants, 29 (3), 728–734.
  • Koschier, F., et al., 2011. In vitro effects of ethanol and mouthrinse on permeability in an oral buccal mucosal tissue construct. Food Chemical Toxicology, 49 (10), 2524–2529.
  • Latimer, J., et al., 2015. Antibacterial efficacy of a cetylpyridinium chloride-based mouthrinse against Fusobacterium nucleatum and in vitro plaques. BMC Microbiology, 28 (Spec No A), 9A–13.
  • Löe, H., and Schiott, C.R., 1970. The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. Journal of Periodontal Research, 5 (2), 79–83.
  • Mariotti, A.J., and Rumpf, D.A., 1999. Chlorhexidine-induced changes to human gingival fibroblast collagen and non-collagen protein production. Journal of Periodontology, 70 (12), 1443–1448.
  • Millhouse, E., et al., 2014. Development of an in vitro periodontal biofilm model for assessing antimicrobial and host modulatory effects of bioactive molecules. BMC Oral Health, 14, 80.
  • Müller, G., and Kramer, A., 2008. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. The Journal of Antimicrobial Chemotherapy, 61 (6), 1281–1287.
  • Mutters, N.T., et al., 2015. The role of Octenidol(®), Glandomed(®) and chlorhexidine mouthwash in the prevention of mucositis and in the reduction of the oropharyngeal flora: a double-blind randomized controlled trial. GMS Hygiene and Infection Control, 10, Doc05.
  • Otten, M.P., et al., 2010. Retention of antimicrobial activity in plaque and saliva following mouthrinse use in vivo. Caries Research, 44 (5), 459–464.
  • Park, J.B., et al., 2014. Comparative effects of chlorhexidine and essential oils containing mouth rinse on stem cells cultured on a titanium surface. Molecular Medicine Reports, 9 (4), 1249–1253.
  • Quirynen, M., et al., 1995. Full- vs. partial-mouth disinfection in the treatment of periodontal infections: short-term clinical and microbiological observations. Journal of Dental Research, 74 (8), 1459–1467.
  • Quirynen, M., et al., 2005. A 0.05% cetyl pyridinium chloride/0.05% chlorhexidine mouth rinse during maintenance phase after initial periodontal therapy. Journal of Clinical Periodontology, 32 (4), 390–400.
  • Sato, S., et al., 2014. Povidone-iodine-induced cell death in cultured human epithelial HeLa cells and rat oral mucosal tissue. Drug and Chemical Toxicology, 37 (3), 268–275.
  • Schmidt, J., et al., 2015. Cytotoxic effects of octenidine mouth rinse on human fibroblasts and epithelial cells – an in vitro study. Drug and Chemical Toxicology, 39 (3), 322–330.
  • Welk, A., et al., 2015. Antibacterial and antiplaque efficacy of a commercially available octenidine-containing mouthrinse. Clinical Oral Investigations, 20 (7), 1469–1476.
  • Zheng, T., et al., 2013. Cetylpyridinium chloride inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast formation. Biological and Pharmaceutical Bulletin, 36 (4), 509–514.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.